» Articles » PMID: 9427149

Mutations Among Italian Mucopolysaccharidosis Type I Patients

Overview
Publisher Wiley
Date 1998 Jan 14
PMID 9427149
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

A group of 27 Italian patients was screened for alpha-L-iduronidase mucopolysaccharidosis type I mutations. Mutations were found in 18 patients, with 28 alleles identified. The two most common mutations in northern Europeans (W402X and Q70X) accounted for 11% and 13% of the alleles, respectively. The R89Q mutation, uncommon in Europeans, was found only in one patient, accounting for 1 of 54 alleles (1.9%). The other mutations, P533R, A327P and G51D, accounted for 11%, 5.6% and 9.3% of the total alleles, respectively. Interestingly, the high frequency of the P533R mutation seems to be confined to Sicily and is higher than the 3% reported in a British/Australian study.

Citing Articles

Lysosomal Dysfunction: Connecting the Dots in the Landscape of Human Diseases.

Uribe-Carretero E, Rey V, Fuentes J, Tamargo-Gomez I Biology (Basel). 2024; 13(1).

PMID: 38248465 PMC: 10813815. DOI: 10.3390/biology13010034.


Epidemiology of mucopolysaccharidoses.

Khan S, Peracha H, Ballhausen D, Wiesbauer A, Rohrbach M, Gautschi M Mol Genet Metab. 2017; 121(3):227-240.

PMID: 28595941 PMC: 5653283. DOI: 10.1016/j.ymgme.2017.05.016.


Report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I.

Kwak M, Huh R, Kim J, Park H, Cho S, Jin D BMC Med Genet. 2016; 17(1):58.

PMID: 27520059 PMC: 4983032. DOI: 10.1186/s12881-016-0319-x.


4-Phenylbutyrate attenuates the ER stress response and cyclic AMP accumulation in DYT1 dystonia cell models.

Cho J, Zhang X, Miller G, Lencer W, Nery F PLoS One. 2014; 9(11):e110086.

PMID: 25379658 PMC: 4224384. DOI: 10.1371/journal.pone.0110086.


Mucopolysaccharidoses in northern Brazil: Targeted mutation screening and urinary glycosaminoglycan excretion in patients undergoing enzyme replacement therapy.

Viana G, de Lima N, Cavaleiro R, Alves E, Souza I, Feio R Genet Mol Biol. 2011; 34(3):410-5.

PMID: 21931511 PMC: 3168179. DOI: 10.1590/S1415-47572011005000025.


References
1.
Yamagishi A, Tomatsu S, Fukuda S, Uchiyama A, Shimozawa N, Suzuki Y . Mucopolysaccharidosis type I: identification of common mutations that cause Hurler and Scheie syndromes in Japanese populations. Hum Mutat. 1996; 7(1):23-9. DOI: 10.1002/(SICI)1098-1004(1996)7:1<23::AID-HUMU3>3.0.CO;2-Q. View

2.
Scott H, Litjens T, Hopwood J, Morris C . A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype. Hum Mutat. 1992; 1(2):103-8. DOI: 10.1002/humu.1380010204. View

3.
Scott H, Litjens T, Nelson P, Brooks D, Hopwood J, Morris C . alpha-L-iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotype. Hum Mutat. 1992; 1(4):333-9. DOI: 10.1002/humu.1380010412. View

4.
Gatti R, BORRONE C, Filocamo M, Pannone N, Di Natale P . Prenatal diagnosis of mucopolysaccharidosis I: A special difficulty arising from an unusually low enzyme activity in mother's cells. Prenat Diagn. 1985; 5(2):149-54. DOI: 10.1002/pd.1970050209. View

5.
Ashton L, Brooks D, McCourt P, Muller V, Clements P, Hopwood J . Immunoquantification and enzyme kinetics of alpha-L-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients. Am J Hum Genet. 1992; 50(4):787-94. PMC: 1682646. View